News April 29, 2019 GSK ramps up investment into Shingrix production GSK announces that it will spend $100m to expand production capacity for components of Shingrix,… Super User 0 Love0
News April 29, 2019 Kite Pharma plans manufacturing facility in Frederick County – Technical.ly Baltimore A Santa Monica, Calif.-based biopharmaceutical company plans to open a facility where it will produce… Super User 0 Love0
News April 29, 2019 IBBR investigator to lead $3.5M NIH-funded project to study immune response to HIV-1 Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received $3.5M from the… Super User 0 Love0
News April 29, 2019 Built For Bio: Pat Larrabee, President of Facility Logix MCEDC learns how Pat’s love for science drove her to found a company in Montgomery… Super User 0 Love0
News April 29, 2019 Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia Nasdaq:AUTL Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for… Super User 0 Love0
News April 29, 2019 Illumina Accelerator Invests in Four New Startups – GenomeWeb Illumina has added four genomics startups to its accelerator program, marking its ninth funding round,… Super User 0 Love0
News April 29, 2019 NIST Releases Findings on Increasing the Innovation Impacts of Federally Funded R&D | NIST Today, the U.S. Department of Commerce’s National Institute of Standards and Technology announced 15 key… Super User 0 Love0
News April 29, 2019 Kite to Open Cell Therapy Manufacturing Facility in Frederick County Creating Significant Job Opportunities In Maryland – BioBuzz Kite Pharma, a California-based biopharmaceutical company that develops innovative cancer immunotherapies, announced plans today to… Super User 0 Love0
News April 29, 2019 GlycoMimetics Announces Enrollment of First Patient in NCI-Sponsored Phase 3 Trial of Uproleselan in AML – Business Wire GlycoMimetics, Inc. (NASDAQ: GLYC) announced today dosing of the first patient in a Phase 3… Super User 0 Love0
News April 29, 2019 3rd Annual Downstream Purification Symposium Bio‑Rad welcomes you to attend the 3rd Annual Downstream Purification Symposium at Institute for Bioscience… Super User 0 Love0